6-K
Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement
6-K
Zhengye Biotechnology Holding Limited Issues Statement Regarding Unusual Trading Activity
6-K
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
6-K
Zhengye Biotechnology Holding Limited Announces Results of 2026 Annual General Meeting
6-K
Zhengye Biotechnology Holding Limited 2026 Annual General Meeting Notice and Proxy Statement
6-K
Zhengye Biotechnology Director Resigns, Causing Nasdaq Compliance Issue
